Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Patricia Mucci LoRusso
Based on 23 articles published since 2009
(Why 23 articles?)
||||
Expertise Level
The expertise of Patricia Mucci LoRusso ranks in the
  • Top 0.15%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 23 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases LoRusso, Pat   ·   LoRusso, Patricia M   ·   Lorusso, Patricia M   ·   LoRusso, Patricia   ·   LoRusso, Patricia Mucci
Work Locations
Details
Most likely:    Yale University   Contact    
2018
  • Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Yale Cancer Center, New Haven, CT, USA. · Department of Medicine and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. · Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. · Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Pubmed 30361524
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 30444904
  • Yale Cancer Center, PO Box 208028, New Haven, CT 06510, USA. · Pubmed 29214842
2017
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · MD Anderson Cancer Center, Madrid, Spain. · Yale Cancer Center, Yale University Medical Center, New Haven, CT, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · F Hoffmann La-Roche Ltd, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 28526538
  • Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Karmanos Cancer Institute, Detroit, Michigan. · Siteman Cancer Center, Washington University, St. Louis, Missouri. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Yale Cancer Center, New Haven, Connecticut. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Pubmed 28298546
  • West Cancer Center, Memphis, Tennessee. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. · Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, Florida. · Department of Internal Medicine, Yale University, New Haven, Connecticut. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Medivation, Inc. (Medivation, Inc., was acquired by Pfizer, Inc., in September 2016), San Francisco, California. · Astellas Pharma, Inc., Northbrook, Illinois. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28280092
  • Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. · Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. · QuantPharm LLC, North Potomac, MD, USA. · The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada. · Institut Paoli-Calmettes, Marseille, France. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Yale Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 27995530
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
2016
  • Breast Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · Weill Cornell Medical College, 445 E 69th St, New York, NY, 10021, USA. · Yale University, 800 Howard Ave, New Haven, CT, 06519, USA. · Stanford Cancer Institute, Stanford University School of Medicine, 900 Blake Wilbur, Stanford, CA, 94305, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, ch-4070, Switzerland. · University of Colorado Cancer Center, 1665 Aurora Ct, Aurora, CO, 80045, USA. · Pubmed 26979312
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA, USA. · Weill Cornell Medical College, New York, NY, USA, USA. · Yale Cancer Center, Yale University, New Haven, CT, USA, USA. · Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA. · Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan. · Planning Department, Kyowa Hakko Kirin Pharma Inc., Princeton, NJ, USA. · Tokyo Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan. · Pubmed 26850678
2015
  • Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America. · Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America. · Pubmed 25774912
2015
  • From the *Breast Cancer Research, Sarah Cannon Research Institute; and †Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN; ‡Dana-Farber Cancer Institute, Boston, MA; §Smilow Cancer Center, Yale University, New Haven, CT; ∥AdvancedBC.org, New York, NY; ¶Genentech, Inc, South San Francisco, CA; and #Mayo Clinic, Jacksonville, FL. · Pubmed 26389758
Probable:    Wayne State University      
2017
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
  • Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee. · Départemement d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France. · INSERM, U981, Villejuif, France. · Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee. · Genentech, Inc., South San Francisco, California. · Karmanos Cancer Institute, Detroit, Michigan. · Pubmed 27815358
2015
  • Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America. · Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America. · Pubmed 25774912
2014
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, South Korea. · MD Anderson Cancer Center, Madrid, Spain. · Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Genentech, South San Francisco, CA, USA. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Pubmed 24793816
2013
  • Karmanos Cancer Institute/Wayne State University, Detroit, MI 48201, USA. · Pubmed 23128843
2010
  • Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Pubmed 21115422
2012
  • Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. · Pubmed 22351688
  • Karmanos Cancer Institute, Wayne State University, 4100 John R, 4HWCRC, Detroit, MI 48201, USA. · Pubmed 22083229
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 23 total) written by Patricia Mucci LoRusso about Breast Neoplasms:

  • Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study. 2018
  • Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer. 2018
  • Trastuzumab emtansine: determining its role in management of HER2+ breast cancer. 2018
  • Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial. 2017
  • (no title) 2017
  • A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer. 2017
  • A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function. 2017
  • Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer. 2017
  • Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors. 2017
  • Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Patricia Mucci LoRusso using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Yale University
Wayne State University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Yale University
2018
  • Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Yale Cancer Center, New Haven, CT, USA. · Department of Medicine and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. · Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. · Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Pubmed 30361524
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 30444904
  • Yale Cancer Center, PO Box 208028, New Haven, CT 06510, USA. · Pubmed 29214842
2017
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · MD Anderson Cancer Center, Madrid, Spain. · Yale Cancer Center, Yale University Medical Center, New Haven, CT, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · F Hoffmann La-Roche Ltd, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 28526538
  • Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Karmanos Cancer Institute, Detroit, Michigan. · Siteman Cancer Center, Washington University, St. Louis, Missouri. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Yale Cancer Center, New Haven, Connecticut. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Pubmed 28298546
  • West Cancer Center, Memphis, Tennessee. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. · Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, Florida. · Department of Internal Medicine, Yale University, New Haven, Connecticut. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Medivation, Inc. (Medivation, Inc., was acquired by Pfizer, Inc., in September 2016), San Francisco, California. · Astellas Pharma, Inc., Northbrook, Illinois. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28280092
  • Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. · Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. · QuantPharm LLC, North Potomac, MD, USA. · The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada. · Institut Paoli-Calmettes, Marseille, France. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Yale Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 27995530
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
2016
  • Breast Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · Weill Cornell Medical College, 445 E 69th St, New York, NY, 10021, USA. · Yale University, 800 Howard Ave, New Haven, CT, 06519, USA. · Stanford Cancer Institute, Stanford University School of Medicine, 900 Blake Wilbur, Stanford, CA, 94305, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, ch-4070, Switzerland. · University of Colorado Cancer Center, 1665 Aurora Ct, Aurora, CO, 80045, USA. · Pubmed 26979312
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA, USA. · Weill Cornell Medical College, New York, NY, USA, USA. · Yale Cancer Center, Yale University, New Haven, CT, USA, USA. · Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA. · Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan. · Planning Department, Kyowa Hakko Kirin Pharma Inc., Princeton, NJ, USA. · Tokyo Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan. · Pubmed 26850678
2015
  • Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America. · Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America. · Pubmed 25774912
2015
  • From the *Breast Cancer Research, Sarah Cannon Research Institute; and †Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN; ‡Dana-Farber Cancer Institute, Boston, MA; §Smilow Cancer Center, Yale University, New Haven, CT; ∥AdvancedBC.org, New York, NY; ¶Genentech, Inc, South San Francisco, CA; and #Mayo Clinic, Jacksonville, FL. · Pubmed 26389758
Wayne State University
2017
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
  • Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee. · Départemement d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France. · INSERM, U981, Villejuif, France. · Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee. · Genentech, Inc., South San Francisco, California. · Karmanos Cancer Institute, Detroit, Michigan. · Pubmed 27815358
2015
  • Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America. · Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America. · Pubmed 25774912
2014
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, South Korea. · MD Anderson Cancer Center, Madrid, Spain. · Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Genentech, South San Francisco, CA, USA. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Pubmed 24793816
2013
  • Karmanos Cancer Institute/Wayne State University, Detroit, MI 48201, USA. · Pubmed 23128843
2010
  • Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Pubmed 21115422
2012
  • Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. · Pubmed 22351688
  • Karmanos Cancer Institute, Wayne State University, 4100 John R, 4HWCRC, Detroit, MI 48201, USA. · Pubmed 22083229
3 Other Locations Show
Yearly article counts 03622116110
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.